Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R6BR
|
||||
| Former ID |
DAP000686
|
||||
| Drug Name |
Amobarbital
|
||||
| Synonyms |
AMAL; Amasust; Amital; Amobarbitale; Amobarbitalum; Amobarbitone; Amospan; Amybal; Amylbarbitone; Amylobarbital; Amylobarbitone; Amytal; Barbamil; Barbamyl; Binoctal; Dorlotyn; Dormytal; Eunoctal; Isomyl; Isomytal; Mylodorm; Pentymal; Pentymalum; Robarb; Schiwanox; Sednotic; Somnal; Stadadorm; Sumital; Talamo; Amobarbital suppository dosage form; Amobarbitale [DCIT]; Barbamyl acid; Component of Dexamyl; Ethylisopentylbarbituric acid; Isoamylethylbarbituric acid; Amobarbital [INN:JAN]; Amobarbitalum [INN-Latin]; Component of 15-90; Component of Amo-Dextrosule; Component of Q-Caps; Isomytal (TN); Amobarbital (JP15/INN); 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-Ethyl-5-(3-methylbutyl)barbituric acid;5-Ethyl-5-isoamylbarbituric acid; 5-Ethyl-5-isoamylmalonyl urea; 5-Ethyl-5-isopentylbarbituric acid; 5-Ethyl-5-isopentylbarbitursaeure; 5-Isoamyl-5-ethylbarbituric acid; 5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione; 5-ethyl-5-(3-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Insomnia; Anxiety disorder [ICD9: 307.41, 307.42, 327.0, 780.51, 780.52, 300, 311; ICD10:F51.0, G47.0, F32, F40-F42] | Approved | [1], [2] | ||
| Therapeutic Class |
Hypnotics and Sedatives
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C11H18N2O3
|
||||
| Canonical SMILES |
CCC1(C(=O)NC(=O)NC1=O)CCC(C)C
|
||||
| InChI |
1S/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)
|
||||
| InChIKey |
VIROVYVQCGLCII-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 57-43-2
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
9739, 75927, 90916, 415152, 4436381, 7847621, 7978707, 8151471, 10527891, 11135452, 11336169, 11361408, 11462380, 11533324, 12587661, 12587662, 15415185, 29221343, 46508165, 47291211, 47891734, 48413208, 48414905, 49857182, 50381613, 53789674, 57321181, 87691678, 93167109, 103165869, 104299793, 124954079, 125308270, 126677737, 129480778, 134337975, 134970867, 137003749, 137240387, 138744645, 144206419, 160964641, 164835791, 175267584, 176262155, 179094982, 179225502, 198993173, 223366878, 223674396
|
||||
| ChEBI ID |
ChEBI:2673
|
||||
| SuperDrug ATC ID |
N05CA02
|
||||
| SuperDrug CAS ID |
cas=000057432
|
||||
| Target and Pathway | |||||
| Target(s) | Gamma-aminobutyric acid receptor subunit alpha-1 | Target Info | Antagonist | [3], [4] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Retrograde endocannabinoid signaling | |||||
| GABAergic synapse | |||||
| Morphine addiction | |||||
| Nicotine addiction | |||||
| Reactome | Ligand-gated ion channel transport | ||||
| GABA A receptor activation | |||||
| WikiPathways | SIDS Susceptibility Pathways | ||||
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||||
| Iron uptake and transport | |||||
| References | |||||
| REF 1 | Drug information of Amobarbital, 2008. eduDrugs. | ||||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
| REF 3 | DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. Epub 2007 Nov 29. | ||||
| REF 4 | Effect of barbiturates on polyphosphoinositide biosynthesis and protein kinase C activity in synaptosomes. Neuropharmacology. 1989 Dec;28(12):1317-23. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.